Skip to content

National study of moderate and severe von Willebrand disease in the Netherlands

National study of moderate and severe von Willebrand disease in the Netherlands - WiN study (Willebrand disease in the Netherlands)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53028
Enrollment
1000
Registered
2007-04-26
Start date
2007-06-15
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bloed- en lymfestelsel aandoeningen: stollingsstoornissen en bloedingsdiathesen von Willebrand disease vWD

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1) haemorrhagic symptoms or a family history of von Willebrand disease 2) vWF antigen

Exclusion criteria

Exclusion criteria: Hemophilia A Carriership of hemophilia A No informed consent

Design outcomes

Primary

MeasureTime frame
See study design

Secondary

MeasureTime frame
See study design

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)